Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Beermeister who wrote (3301)	2/18/1999 2:59:00 PM
From: Seacoast	Read Replies (1) \| Respond to of 4650

ADOT is being picked up br Wall Street West. Is this good?

To: Beermeister who wrote (3301)	2/18/1999 3:05:00 PM
From: Jay D.	Read Replies (3) \| Respond to of 4650

Looking over BIOMODA website I see no evidence of INDEPENDENT outside studies of their cancer test in order to validate it. It is all company generated which means to me that it is just smoke and mirrors, something as breakthru as a lung cancer test that detects 6 years earlier than any other would have tons of medical journal articles and reviews that give it credability. Biomoda has one article that describes the process but does not discuss its merit. IMDS was one with tons of endorsements from the medical world for its breast cancer screening that was going through phase 1 testing and selling at $4, now it is a penny stock. I'm sorry I don't buy into something without at least REAL endorsements from the medical world. JMO